港股异动 | 阿里健康(00241)涨近4% 与北京梅尔森医药达成战略合作贝美净®将于本周二全网首发

智通财经01-12

智通财经APP获悉，阿里健康(00241)涨近4%，截至发稿，涨3.29%，报5.96港元，成交额5.19亿港元。消息面上，据阿里健康官微消息，1月8日，阿里健康与北京梅尔森医药技术开发有限公司达成战略合作，共同宣布将在儿童专科创新药领域展开深度合作。双方将围绕全球首款获批用于治疗增殖期浅表性婴儿血管瘤的外用创新药——贝美净®(马来酸噻吗洛尔凝胶)，开展从患者教育、公益援助到全渠道首发的深度协同。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2602567685?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-12 11:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602567685","market":"us","top_or_hot":-1,"title":"港股异动 | 阿里健康(00241)涨近4% 与北京梅尔森医药达成战略合作 贝美净®将于本周二全网首发","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，阿里健康(00241)涨近4%，截至发稿，涨3.29%，报5.96港元，成交额5.19亿港元。消息面上，据阿里健康官微消息，1月8日，阿里健康与北京梅尔森医药技术开发有限公司达成战略合作，共同宣布将在儿童专科创新药领域展开深度合作。双方将围绕全球首款获批用于治疗增殖期浅表性婴儿血管瘤的外用创新药——贝美净®(马来酸噻吗洛尔凝胶)，开展从患者教育、公益援助到全渠道首发的深度协同。...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1391466.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 阿里健康(00241)涨近4% 与北京梅尔森医药达成战略合作 贝美净®将于本周二全网首发</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 阿里健康(00241)涨近4% 与北京梅尔森医药达成战略合作 贝美净®将于本周二全网首发\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-12 11:25 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1391466.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，阿里健康(00241)涨近4%，截至发稿，涨3.29%，报5.96港元，成交额5.19亿港元。消息面上，据阿里健康官微消息，1月8日，阿里健康与北京梅尔森医药技术开发有限公司达成战略合作，共同宣布将在儿童专科创新药领域展开深度合作。双方将围绕全球首款获批用于治疗增殖期浅表性婴儿血管瘤的外用创新药——贝美净®(马来酸噻吗洛尔凝胶)，开展从患者教育、公益援助到全渠道首发的深度协同。...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1391466.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1142","symbol_name":"互联网与直销零售","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1391466.html","article_id":"2602567685","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602567685","pubTimestamp":1768188329,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，阿里健康涨近4%，截至发稿，涨3.29%，报5.96港元，成交额5.19亿港元。消息面上，据阿里健康官微消息，1月8日，阿里健康与北京梅尔森医药技术开发有限公司达成战略合作，共同宣布将在儿童专科创新药领域展开深度合作。贝美净不仅是全球首个针对该适应症的外用凝胶剂型，也标志着我国在儿童专用改良型新药研发领域取得了从科研创新到产业转化的重大突破。贝美净将于1月13日在阿里健康全网独家首发。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","BK1142":"互联网与直销零售","BK1591":"就地过年概念","BK1584":"蚂蚁金服概念","BK1502":"双十一","BK1571":"互联网医疗","BK1189":"医疗保健技术","BK1617":"AI医疗","09939":"开拓药业-B","BK1589":"北水核心资产","BK1615":"港股-互联网","BK1515":"抗疫概念","BK1501":"阿里概念股","BK1610":"ETF&股票定投概念","00241":"阿里健康","BK1574":"生物医药B类股","BK1161":"生物科技","BK1247":"药品零售"},"translate_title":"Changes in Hong Kong stocks | Alibaba Health (00241) rose nearly 4% and reached a strategic cooperation with Beijing Melson Pharmaceuticals ® Will be launched on the whole network this Tuesday","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1.5,"00241":1.5,"09939":1.5},"content_text":"智通财经APP获悉，阿里健康(00241)涨近4%，截至发稿，涨3.29%，报5.96港元，成交额5.19亿港元。消息面上，据阿里健康官微消息，1月8日，阿里健康与北京梅尔森医药技术开发有限公司达成战略合作，共同宣布将在儿童专科创新药领域展开深度合作。双方将围绕全球首款获批用于治疗增殖期浅表性婴儿血管瘤的外用创新药——贝美净®(马来酸噻吗洛尔凝胶)，开展从患者教育、公益援助到全渠道首发的深度协同。据悉，长期以来，国内缺乏专为婴幼儿设计的外用血管瘤治疗药物。贝美净®不仅是全球首个针对该适应症的外用凝胶剂型，也标志着我国在儿童专用改良型新药研发领域取得了从科研创新到产业转化的重大突破。贝美净®(马来酸噻吗洛尔凝胶)将于1月13日在阿里健康全网独家首发。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602567685","isCrawlerRequest":true}

港股异动 | 阿里健康(00241)涨近4% 与北京梅尔森医药达成战略合作 贝美净®将于本周二全网首发

精彩评论

港股异动 | 阿里健康(00241)涨近4% 与北京梅尔森医药达成战略合作贝美净®将于本周二全网首发